Onescope
Onescope is a Swiss-based company revolutionizing respiratory care with its AI-powered 3-in-1 medical device called Pneumoscope, which combines a digital stethoscope, pulse oximeter, and thermometer. Initiated at Geneva University Hospitals and developed with EPFL and HEPIA, the device decentralizes diagnosis, monitoring, and management of respiratory diseases by providing real-time analysis and personalized care recommendations through an intuitive app. The company targets both low- and middle-income countries to democratize access to high-quality respiratory care and high-income countries to enhance remote patient monitoring, aiming to improve outcomes and reduce healthcare costs. Onescope's patented technology and AI algorithms have been validated in clinical studies and published in Nature Digital Medicine, positioning it as a leader in AI-driven respiratory diagnostics with significant traction and multiple awards.
Onescope
Onescope is a Swiss-based company revolutionizing respiratory care with its AI-powered 3-in-1 medical device called Pneumoscope, which combines a digital stethoscope, pulse oximeter, and thermometer. Initiated at Geneva University Hospitals and developed with EPFL and HEPIA, the device decentralizes diagnosis, monitoring, and management of respiratory diseases by providing real-time analysis and personalized care recommendations through an intuitive app. The company targets both low- and middle-income countries to democratize access to high-quality respiratory care and high-income countries to enhance remote patient monitoring, aiming to improve outcomes and reduce healthcare costs. Onescope's patented technology and AI algorithms have been validated in clinical studies and published in Nature Digital Medicine, positioning it as a leader in AI-driven respiratory diagnostics with significant traction and multiple awards.
TL;DR
Headquarters: Geneva (Cologny), Switzerland
Product: Pneumoscope — AI-powered 3-in-1 device (digital stethoscope, pulse oximeter, thermometer) with mobile app
Founders: Prof. Alain Gervaix (Co-founder & CEO), Yannick Ormen (Co-founder & COO)
Clinical validation: AI algorithms and device validated in clinical studies
Funding (reported): Grant CHF 10,000 (Feb 13, 2023)
Company Overview
Problem Domain
Respiratory disease diagnosis, monitoring, and remote patient management
Industry
Medtech
Funding Track Record
CHF 10,000
Reported as a grant funding event